54
Participants
Start Date
August 2, 2022
Primary Completion Date
April 25, 2023
Study Completion Date
April 25, 2023
Remimazolam Besylate
Remimazolam Besylate is used as intervention drug for general anesthesia, which followed by flumazenil administration at the end of anesthesia, to be compared to propofol total intravenous anesthesia during radiofrequency catheter ablation of atrial fibrillation.
Flumazenil
Flumazenil is used as additional intervention drug to facilitate emergence from general anesthesia in the Remimazolam with Flumazenil group.
Propofol
Propofol is used as active comparator drug for general anesthesia until the end of anesthesia, to be compared to remimazolam besylate during radiofrequency catheter ablation of atrial fibrillation.
Seoul National University Hospital, Seoul
Seoul National University Hospital
OTHER